Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria A Rodriguez

Showing results (31-40 of 77) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|March 31, 2015
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approachYasuhiro Oki, Sattva S Neelapu, Michelle Fanale, et al.
International Journal of Molecular Sciences|September 28, 2024
Deoxynivalenol Induces Local Inflammation and Lesions in Tissues at Doses Recommended by the EUAlix Pierron, Luciana C Balbo, Laura Soler, et al.
Cancer|July 13, 2002
International prognostic index-based outcomes for diffuse large B-cell lymphomasRichard B Wilder, Maria A Rodriguez, L Jeffrey Medeiros, et al.
Polymers|June 10, 2022
Blood-Vessel-Inspired Hierarchical Trilayer Scaffolds: PCL/Gelatin-Driven Protein Adsorption and Cellular InteractionMaria A Rodriguez-Soto, Andres J Garcia-Brand, Alejandra Riveros, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapyGregory M Chronowski, Richard B Wilder, Susan L Tucker, et al.
British Journal of Haematology|July 5, 2007
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphomaNam H Dang, Luis Fayad, Peter McLaughlin, et al.
Leukemia & Lymphoma|November 22, 2011
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national databaseGregory A Abel, Ann Vanderplas, Maria A Rodriguez, et al.
Blood|October 24, 2002
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphomaApostolia M Tsimberidou, Peter McLaughlin, Anas Younes, et al.
Leukemia & Lymphoma|February 25, 2015
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphomaNina D Wagner-Johnston, Andrè Goy, Maria A Rodriguez, et al.
American Journal of Clinical Oncology|February 6, 2004
Second malignancies after chemotherapy and radiotherapy for Hodgkin diseaseGregory M Chronowski, Richard B Wilder, Larry B Levy, et al.
Pageof 8

Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|March 31, 2015
Detection of classical Hodgkin lymphoma specific sequence in peripheral blood using a next-generation sequencing approachYasuhiro Oki, Sattva S Neelapu, Michelle Fanale, et al.
International Journal of Molecular Sciences|September 28, 2024
Deoxynivalenol Induces Local Inflammation and Lesions in Tissues at Doses Recommended by the EUAlix Pierron, Luciana C Balbo, Laura Soler, et al.
Cancer|July 13, 2002
International prognostic index-based outcomes for diffuse large B-cell lymphomasRichard B Wilder, Maria A Rodriguez, L Jeffrey Medeiros, et al.
Polymers|June 10, 2022
Blood-Vessel-Inspired Hierarchical Trilayer Scaffolds: PCL/Gelatin-Driven Protein Adsorption and Cellular InteractionMaria A Rodriguez-Soto, Andres J Garcia-Brand, Alejandra Riveros, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2002
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapyGregory M Chronowski, Richard B Wilder, Susan L Tucker, et al.
British Journal of Haematology|July 5, 2007
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphomaNam H Dang, Luis Fayad, Peter McLaughlin, et al.
Leukemia & Lymphoma|November 22, 2011
High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national databaseGregory A Abel, Ann Vanderplas, Maria A Rodriguez, et al.
Blood|October 24, 2002
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphomaApostolia M Tsimberidou, Peter McLaughlin, Anas Younes, et al.
Leukemia & Lymphoma|February 25, 2015
A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphomaNina D Wagner-Johnston, Andrè Goy, Maria A Rodriguez, et al.
American Journal of Clinical Oncology|February 6, 2004
Second malignancies after chemotherapy and radiotherapy for Hodgkin diseaseGregory M Chronowski, Richard B Wilder, Larry B Levy, et al.
Pageof 8